Targeted Minicircle Technologies is a biotech drug and vaccine discovery company with expertise in cancer and infectious diseases. Our strength is to connect various cutting-edge discoveries with minicircle-DNA technology and synergize specific aspects of emerging trends. Utilizing various online databases, collaborations, and AI-based approach we intend reduce the traditional drug and vaccine developmental processes to a fraction of its time.
To revolutionize global healthcare by pioneering innovative vaccine and immunotherapy technologies, leading the way towards safer, more effective treatments for complex and emerging diseases.
To transform the landscape of medical treatment through groundbreaking advancements in Minicircle-DNA vaccines and CAR T cell therapies, overcoming critical challenges in solid tumor treatment, and enhancing the safety and efficacy of next-generation therapies for the betterment of human health worldwide.
